Correction: Fahmy et al. Optimized Icariin Cubosomes Exhibit Augmented Cytotoxicity against SKOV-3 Ovarian Cancer Cells. Pharmaceutics 2021, 13, 20
Error in Figure
Text Correction
Reference
- Fahmy, U.A.; Fahmy, O.; Alhakamy, N.A. Optimized Icariin Cubosomes Exhibit Augmented Cytotoxicity against SKOV-3 Ovarian Cancer Cells. Pharmaceutics 2021, 13, 20. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Fahmy, U.A.; Fahmy, O.; Alhakamy, N.A. Correction: Fahmy et al. Optimized Icariin Cubosomes Exhibit Augmented Cytotoxicity against SKOV-3 Ovarian Cancer Cells. Pharmaceutics 2021, 13, 20. Pharmaceutics 2025, 17, 145. https://doi.org/10.3390/pharmaceutics17020145
Fahmy UA, Fahmy O, Alhakamy NA. Correction: Fahmy et al. Optimized Icariin Cubosomes Exhibit Augmented Cytotoxicity against SKOV-3 Ovarian Cancer Cells. Pharmaceutics 2021, 13, 20. Pharmaceutics. 2025; 17(2):145. https://doi.org/10.3390/pharmaceutics17020145
Chicago/Turabian StyleFahmy, Usama A., Omar Fahmy, and Nabil A. Alhakamy. 2025. "Correction: Fahmy et al. Optimized Icariin Cubosomes Exhibit Augmented Cytotoxicity against SKOV-3 Ovarian Cancer Cells. Pharmaceutics 2021, 13, 20" Pharmaceutics 17, no. 2: 145. https://doi.org/10.3390/pharmaceutics17020145
APA StyleFahmy, U. A., Fahmy, O., & Alhakamy, N. A. (2025). Correction: Fahmy et al. Optimized Icariin Cubosomes Exhibit Augmented Cytotoxicity against SKOV-3 Ovarian Cancer Cells. Pharmaceutics 2021, 13, 20. Pharmaceutics, 17(2), 145. https://doi.org/10.3390/pharmaceutics17020145